Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.2 Form of Amended and Restated Certificate of Incorporation
- 3.4 Form of Amended and Restated Bylaws of the Registrant
- 10.1 Form of Indemnification Agreement
- 10.4 2011 Equity Incentive Plan
- 10.5 Forms of Stock Option Grant Notice, Stock Option Excercise Notice And....
- 10.6 Form of Restricted Stock Unit Award Agreement
- 10.7 2011 Employee Stock Purchase Plan
- 10.11 Founder's Vesting Agreement - Pamela Palmer
- 10.12 Founder's Vesting Agreement - Thomas Schreck
- 10.13 Offer Letter - Thomas Schreck
- 10.14 Amended and Restated Offer Letter - Larry Hamel
- 10.15 Amended and Restated Offer Letter - Badri (Anil) Dasu
- 10.16 Amended and Restated Offer Letter - Pamela Palmer
- 10.17 Amended and Restated Offer Letter - Richard King
- 10.18 Amended and Restated Offer Letter - James Welch
- 10.19 Resignation Agreement - Thomas Schreck
- 23.1 Consent of Independent Registered Public Accounting Firm
- CORRESP Corresp
TLPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2010, in the Registration Statement (Amendment No. 2 to Form S-1) and related Prospectus of AcelRx Pharmaceuticals, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Francisco, California
January 7, 2011